Abstract

To the Editor: Fibromyalgia is a syndrome characterized by chronic, widespread pain in combination with tenderness to palpation at specific tender point sites on the body, in the absence of otherwise apparent organic disease [1]. Given the unclear etiology of fibromyalgia, and the heterogeneous presentations of the disease, it has become clear that no one therapy is broadly efficacious. Drugs known to attenuate glial activation and secretion of proinflammatory cytokines such as naltrexone have already been tested and found efficient in the reduction of fibromyalgia symptoms [2]. Glial cell activation and subsequent secretion of cytokines constitute one of the theories underlying fibromyalgia syndrome. Glial cells, long …

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.